An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential-Reference-Cited by-同舟云学术

An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential

Published:2018-05 Issue:6 Volume:173 Page:1413-1425.e14
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Wang Liqin,Leite de Oliveira Rodrigo,Huijberts Sanne,Bosdriesz Evert,Pencheva Nora,Brunen Diede,Bosma Astrid,Song Ji-Ying,Zevenhoven John,Los-de Vries G. Tjitske,Horlings Hugo,Nuijen Bastiaan,Beijnen Jos H.,Schellens Jan H.M.,Bernards Rene

Funder

Dutch Cancer Society (KWF

European Research Council (ERC

Center for Cancer Genomics (CGC.nl

ERC

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference36 articles.

1. Resistance to BRAF inhibitors induces glutamine dependency in melanoma cells;Baenke;Mol. Oncol.,2016

2. Role of membrane transport in metabolism and function of glutathione in mammals;Bannai;J. Membr. Biol.,1986

3. Mitochondrial oxidative stress is the Achilles’ heel of melanoma cells resistant to Braf-mutant inhibitor;Corazao-Rozas;Oncotarget,2013

4. Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance;Das Thakur;Nature,2013

5. Increased cystine uptake capability associated with malignant progression of Nb2 lymphoma cells;Gout;Leukemia,1997

Cited by 256 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer plasticity in therapy resistance: Mechanisms and novel strategies;Drug Resistance Updates;2024-09

2. GSH exhaustion via inhibition of xCT-GSH-GPX4 pathway synergistically enhanced DSF/Cu-induced cuproptosis in myelodysplastic syndromes;Free Radical Biology and Medicine;2024-09

3. In vivo vulnerabilities to GPX4 and HDAC inhibitors in drug-persistent versus drug-resistant BRAFV600E lung adenocarcinoma;Cell Reports Medicine;2024-08

4. Discovery of the Inhibitor Targeting the SLC7A11/xCT Axis through In Silico and In Vitro Experiments;International Journal of Molecular Sciences;2024-07-29

5. PART1 facilitates tumorigenesis and inhibits ferroptosis by regulating the miR-490-3p/SLC7A11 axis in hepatocellular carcinoma;Aging;2024-07-05